Post marketing study of sofosbuvir and ribavirin for hepatitis C virus genotype 2 infectio
Not Applicable
- Conditions
- Hepatitis C virus infection
- Registration Number
- JPRN-UMIN000023269
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)pregnant woman 2)decompensated cirrhosis 3)severe renal function(<eGFR30)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sustained virological response at 12 weeks after the end of treatment
- Secondary Outcome Measures
Name Time Method